Booth Andrew
SEC insider (Form 3/4/5 filer). CIK 0001834411. Chief Financial Officer at AbCellera Biologics Inc. (ABCL). 5 reported Form 4/5 transactions since Sep 2024; latest on Aug 14, 2026. Located in VANCOUVER.
Companies Booth Andrew has filed insider reports for
- AbCellera Biologics Inc. (ABCL): Officer, Chief Financial Officer
Booth Andrew
CIK: 0001834411
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
AbCellera Biologics Inc.
Discretionary Trading P&L
Holdings
Transaction History (5 total)
- Aug 14, 2026ABCL
AbCellera Biologics Inc.
PurchaseDirect37.2K shares at avg. $10.32$384K - Jun 3, 2026ABCL
AbCellera Biologics Inc.
ExerciseDirect250K shares at avg. $0.19$48K - Feb 27, 2026ABCL
AbCellera Biologics Inc.
PurchaseDirect42.6K shares at avg. $3.42$146K - Jan 1, 2026ABCL
AbCellera Biologics Inc.
AwardDirectShare option (right to buy)
808.9K shares- - Jan 1, 2025ABCL
AbCellera Biologics Inc.
AwardDirectShare option (right to buy)
1.4M shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Aug 14, 2026 | ABCL AbCellera Biologics Inc. | Purchase | 37,200 | $10.32 | $383,904 | Direct |
| Jun 3, 2026 | ABCL AbCellera Biologics Inc. | Exercise | 250,000 | $0.19 | $47,500 | Direct |
| Feb 27, 2026 | ABCL AbCellera Biologics Inc. | Purchase | 42,600 | $3.42 | $145,692 | Direct |
| Jan 1, 2026 | ABCL AbCellera Biologics Inc. | Award Share option (right to buy) | 808,898 | - | - | Direct |
| Jan 1, 2025 | ABCL AbCellera Biologics Inc. | Award Share option (right to buy) | 1,352,054 | - | - | Direct |
1-5 of 5 transactions